Want a pharma connection to President Obama's new Supreme Court nominee Elana Kagan? As U.S. Solicitor General, Kagan backed the shareholders who were suing Merck (NYSE: MRK) over claims that the company misrepresented the safety of Vioxx; Kagan agreed that the investors hadn't waited past the statute of limitations to file the lawsuits. Report
Virtual Clinical Trials Summit
Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials
In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.
